Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001104659-19-069143
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-02 20:07:10
Reporting Period:
2019-11-29
Accepted Time:
2019-12-02 20:07:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1083446 Apollo Medical Holdings Inc. AMEH Services-Management Consulting Services (8742) 870042699
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1725602 Allied Physicians Of California, A Profession Medical Corp 1668 S. Garfield Ave.
2Nd Floor
Alhambra CA 91801
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-29 6,500 $18.46 16,899,778 No 4 P Direct
Common Stock Acquisiton 2019-12-02 18,602 $17.94 16,918,380 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $18.30 to $18.60. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. This transaction was executed in multiple trades at prices ranging from $17.72 to $18.11. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.